Benefits and risks of protracted treatment with human recombinant erythropoietin in patients having haemodialysis.
about
Cost benefits of low dose subcutaneous erythropoietin in patients with anaemia of end stage renal disease.Alterations of erythrocyte rheology and cellular susceptibility in end stage renal disease: Effects of peritoneal dialysisA rare cause of visual loss in AIDS patients: central retinal vein occlusion.The use of erythropoietin in renal failure.Treating renal anaemia with recombinant human erythropoietin: practical guidelines and a clinical algorithm.Erythropoietin: the developing story.The use of erythropoietin in a Jehovah's Witness undergoing major surgery and chemotherapy.Recombinant human erythropoietin inhibits iNOS activity and reverts vascular dysfunction in splanchnic artery occlusion shock.
P2860
Q35819853-9DB22FAA-3FBE-4B19-8245-6403FDFF7A39Q36269951-974B9DF3-C812-4644-A060-483158D64ADAQ37477216-DFBF4AD0-EEB7-4B97-9653-9458994E95EAQ37767350-68299DD0-786D-40DA-96BF-B9620AA72B0DQ38066210-203B44D0-4D1B-46CD-A25A-B5CA1E726760Q42133813-5E32C9A2-6230-4450-A46F-7AEB63132C5FQ42383398-9511C41D-D884-46DE-A054-E98B57A112C6Q43192136-195DD705-BC31-49FC-B03A-36C7E4470929
P2860
Benefits and risks of protracted treatment with human recombinant erythropoietin in patients having haemodialysis.
description
1987 nî lūn-bûn
@nan
1987 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Benefits and risks of protract ...... patients having haemodialysis.
@ast
Benefits and risks of protract ...... patients having haemodialysis.
@en
Benefits and risks of protract ...... patients having haemodialysis.
@nl
type
label
Benefits and risks of protract ...... patients having haemodialysis.
@ast
Benefits and risks of protract ...... patients having haemodialysis.
@en
Benefits and risks of protract ...... patients having haemodialysis.
@nl
prefLabel
Benefits and risks of protract ...... patients having haemodialysis.
@ast
Benefits and risks of protract ...... patients having haemodialysis.
@en
Benefits and risks of protract ...... patients having haemodialysis.
@nl
P2093
P2860
P1433
P1476
Benefits and risks of protract ...... patients having haemodialysis.
@en
P2093
Campise MR
Graziani G
Passerini P
Ponticelli C
P2860
P304
P407
P577
1987-10-01T00:00:00Z